SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $59,843 | -66.2% | 12,953 | -61.9% | 0.00% | -100.0% |
| Q2 2022 | $177,000 | -48.4% | 34,041 | -18.4% | 0.00% | 0.0% |
| Q1 2022 | $343,000 | -39.0% | 41,716 | +10.4% | 0.00% | 0.0% |
| Q4 2021 | $562,000 | +165.1% | 37,800 | +236.7% | 0.00% | 0.0% |
| Q3 2021 | $212,000 | -67.3% | 11,228 | -67.8% | 0.00% | -50.0% |
| Q2 2021 | $648,000 | +125.0% | 34,877 | +21.7% | 0.00% | -50.0% |
| Q3 2020 | $288,000 | +23.6% | 28,661 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $233,000 | -42.0% | 29,980 | -23.8% | 0.00% | -60.0% |
| Q1 2020 | $402,000 | +31.4% | 39,365 | +41.5% | 0.01% | +400.0% |
| Q4 2019 | $306,000 | +61.1% | 27,818 | +32.8% | 0.00% | 0.0% |
| Q3 2019 | $190,000 | +33.8% | 20,951 | +67.7% | 0.00% | +100.0% |
| Q2 2019 | $142,000 | – | 12,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |